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Background: The relative rarity and anatomical position of retrorectal tumors may lead to 
difficulty in diagnosis and surgical management.
Methods: This was a retrospective review of 62 patients who had resection of retrorectal tumors 
between 2002 and 2010.
Results: All patients in this study were treated by excision of the retrorectal tumors. Surgical 
approach included transsacral approach (52 cases), transabdominal approach (eight cases), and 
combined approach (two cases). A total of 48 benign lesions (77.4%) and 14 malignant lesions 
(22.6%) were confirmed by histological examination. The 48 benign cases included dermoid 
cysts (17 cases), simple cysts (eight cases), teratomas (eight cases), neurofibromas (eight 
cases), fi  brolipomas (four cases), neurilemmomas (two cases), and synovioma (one case). The 
14 malignant cases included lymphomas (four cases), malignant teratomas (three cases), 
  fibrosarcomas (two cases), interstitialomas (four cases) and malignant mesothelioma (one case). 
Complications occurred in 14.5% of patients and included intraoperative bleeding (three 
cases), rectal injury (three cases), and presacral infection (three cases).
Conclusion: Primary retrorectal tumors are very rare. Successful treatment of these tumors 
requires extensive knowledge of pelvic anatomy and expertise in pelvic surgery.
Keywords: retrorectal space, retrorectal tumor, surgical treatment
Background
Tumors within the retrorectal space are uncommon and due to their rarity and 
diverse symptoms they are often misdiagnosed or mistreated. Tumors occurring in 
the   retrorectal space are extremely rare in the adult population, with an estimated 
incidence of 0.0025–0.014 in large referral centers.1 Retrorectal tumors may be 
  classified as congenital, neurogenic, osseous, or miscellaneous.2 Two-thirds are 
congenital, caused by embryological sequestration, abnormalities in midline fusion, 
and incomplete embryological regression. Cystic congenital lesions include   epidermoid 
and dermoid cysts, tailgut cyst (also called cystic hamartoma or mucus-secreting cyst), 
enterogenic cyst, teratoma, and teratocarcinoma.2,3 Neurogenic (including anterior sacral 
meningoceles), osseous, and miscellaneous tumors each account for approximately 
10% of retrorectal tumors.2,3 Retrorectal tumors remain a difficult diagnostic and 
therapeutic challenge despite the use of newer imaging modalities and improvements 
in perioperative care. The diagnosis of these lesions requires a high index of suspicion, 
and treatment should be undertaken only by surgeons with expertise in complex pelvic 
operations.2 Most retrorectal tumors ultimately require surgical resection. Complete 
resection with negative margins is the standard for benign retrorectal tumors, but it OncoTargets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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is more difficult to resect malignant tumors to bring about 
a cure, and the tumors tend to recur locally. The aim of this 
study was to review the authors’ surgical experience with 
retrorectal tumors over the past 9 years.
Methods
The clinical records of a series of 62 patients who underwent 
surgery for retrorectal tumors from 2002 to 2010 at the 
Department of Coloproctological Surgery, First   Affiliated 
Hospital, College of Medicine, Zhejiang University, were 
reviewed. Patient demographics, symptoms, physical 
  findings, investigations, surgical interventions, pathology, and 
complications were all documented. Follow-up   information 
was supplemented by means of a telephone interview with 
each patient. The study received ethics board approval at 
First Affiliated Hospital.
Results
A total of 62 patients underwent surgery for a retrorectal tumor, 
of which 23 were men and 39 women. Ages ranged from 15 to 
68 years (median 40.5), with 67.7% of them aged ,40 years 
(42 cases). The clinical course ranged from 1 week to 10 years 
(median 10.2 months). Forty-five patients were preliminarily 
diagnosed and 17 were follow-up patients. The diameter of the 
tumors ranged from 3 to 15 cm. Twenty-four patients (38.7%) 
were asymptomatic and the retrorectal mass were discovered 
on routine screening rectal examination. In the remaining 
38 (62.3%) patients, 22 complained of pain in lumbosacral area 
and eight in the hypogastric area, while eight had a palpable 
mass on physical examination. Seven patients (14.5%) had 
difficulty defecating, four (8.3%) had lower extremity pain, 
three (6.25%) had lower extremity edema, two (4.1%) had 
dysuria, and two (4.1%) had perineal fistulae.
Forty patients underwent routine ultrasonography as 
the only diagnostic evaluation. Of the 28 patients diag-
nosed, twelve had solid or solid cystic tumors. Eight   
of the 28 patients with cystic tumors underwent transrectal 
ultrasound during their initial evaluation for a retrorectal 
mass, all being reported presacral tumors. Fifteen patients 
received pelvic plain radiographs. Eight of them showed 
calcification in the presacral area, three had compression-
induced sacral and vertebral deformity, and one showed 
pelvic wall involvement with bony destruction, while the 
remaining three patients did not show any positive signs. 
Twenty patients underwent computed tomography scans to 
confirm the diagnosis (Figure 1). The border of the presacral 
mass was clear in twelve and unclear in eight of them.   Pelvic 
magnetic resonance imaging (MRI) was performed on twelve 
suspected cases (Figure 2A and B), in which ten of the masses 
were in the presacral area and two were of rectal origin. Other 
imaging modalities such as contrast perineum fistulography 
were used in two cases.
All patients in this study were treated with excision of 
the retrorectal tumors. The surgical approach included trans-
sacral approach in 48 cases, transabdominal approach in eight 
cases, and combined abdominosacral approach in six cases. 
Four of the 52 cases which underwent transsacral approach 
were intraoperatively converted to a combined approach. 
The excisions were microscopically complete in 52 cases. 
With an additional six palliative resections, the resection rate 
was 93.5%. One teratocarcinoma with rectum involvement 
received a combined resection of tumor and rectum followed 
by a coloproctostomy. Three lymphomas with extensive 
rectal, sacrococcygeal, pelvic, and mesenteric lymph node 
metastasis had simple sigmoid colostomies.
Complications occurred in 14.5% of patients. There 
were three intraoperative bleedings (of more than 800 mL), 
including one benign and two malignant cases. There were 
also three rectal injuries, one receiving simple repair of the 
rectum and the other two receiving partial rectal resection 
with rectal anastomosis. Presacral infection occurred in three 
cases after operation. Two of these were cured after sufficient 
drainage and the other received an additional epluchage after 
1 month of drainage, which was considered successful.
A total of 48 benign (77.4%) and 14 malignant (22.6%) 
lesions were confirmed by histological examination 
(Table 1). The 48 benign cases included 17 dermoid cysts, 
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underappreciated by clinicians and the tumors are commonly 
misdiagnosed, even after extensive radiological workup.3 
The majority of retrorectal tumors are benign; malignant 
tumors are notoriously difficult to excise for a cure, although 
they can be slow growing and rarely metastasize until late 
in their course.
Retrorectal tumors are frequently asymptomatic and 
are often found incidentally during evaluation for   unrelated 
physical complaints. Furthermore, even patients with 
symptoms directly referable to a retrorectal tumor may be 
initially misdiagnosed as having fistulae in ano; pilonidal 
cysts; perianal abscesses; psychogenic, post-traumatic, or 
postpartum pain; or proctalgia fugax. In fact, Singer et al 
found that patients underwent an average of 4.1 surgical 
procedures before being correctly diagnosed with primary 
retrorectal pathology.2
Retrorectal tumors may produce minimal or vague 
symptoms for long periods of time. In fact, benign lesions 
are most often aymptomatic.4 Patients may initially complain 
of constipation, paradoxical diarrhea, or frequent urge to 
defecate, as the tumor causes compression of the adjacent 
rectum. Previously, retrorectal tumors in women were 
  occasionally diagnosed during labor as the cause of dystocia. 
Pain (either pelvic discomfort or sciatic symptoms) is more 
common with malignant retrorectal tumors. Two large 
series have demonstrated that pain is present in 86%–88% 
of patients with malignancy versus 22%–39% of those with 
benign lesions.2,3 Other factors predictive of malignancy 
include male gender, and age .60 years. Chordomas are 
classically associated with constant dull aching in the low 
back, pelvis, and buttocks. This pain is typically worsened by 
sitting and relieved with standing or walking. Patients with 
anterior sacral meningoceles may complain of headaches 
Table 1 Histopathological findings and clinical outcome
Histopathology n (%) Recurrence
Benign 48 (77.4)
  Dermoid cyst 17 (27.4) none
  simple cyst 8 (12.9) none
  Teratoma 8 (12.9) 1 (1 episode)
  Neurofibroma 8 (12.9) 2 (1 episode)
  Fibrolipoma 4 (6.5) 1 (1 episode)
  neurilemmoma 2 (3.2) none
  synovioma 1 (1.6) none
Malignant 14 (22.6)
  Lymphoma 4 (6.5) 1 (local)
  interstitialoma 4 (6.5) 1 (local)
  Malignant teratoma 3 (4.8) 1 (local)
  Fibrosarcoma 2 (3.2) none
  Malignant mesothelioma 1 (1.6) none
Figure  2  Magnetic  resonance  imaging  images  of  dermoid  cyst  (A)  and  fibro­
sarcoma (B).
eight simple cysts, eight teratomas, eight neurofibromas, four 
fibrolipomas, two neurilemmomas and one synovioma. The 
14 malignancy included four lymphomas, three   malignant 
teratomas, two fibrosarcomas, four interstitialomas, and 
one malignant mesothelioma. Forty-five patients were 
followed-up for 6 months to 9 years, and seven of them 
experienced at least one episode of recurrence, including two 
neurofibromas and one local recurrence of interstitialoma.
Discussion
Primary tumors of the retrorectal (or presacral) space are rare 
lesions. Retrorectal tumors produce symptoms that are often OncoTargets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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after straining during defecation or intercourse, and their 
symptoms may be reproduced with Valsalva.5 The diagnosis 
of retrorectal cyst should be suspected in any patient with a 
history of repeated attempts at drainage for a fistula in ano or 
perirectal abscess, especially when no obvious internal rectal 
opening can be identified or mucoid material (rather than pus) 
is drained.6 Malignant tumors that invade the sacral plexus 
or nerve roots can lead to bowel and bladder incontinence 
or urinary retention.
All patients with suspected retrorectal tumors should 
undergo complete colonoscopy and women should have 
detailed bimanual pelvic examinations to exclude the much 
more common conditions of colorectal or ovarian/uterine 
adenocarcinomas, respectively. The rectal mucosa overlying 
a retrorectal tumor appears normal. Small lesions may not 
be detectable on proctoscopy, but larger lesions demonstrate 
extraluminal compression of the rectum. Traditionally, 
evaluation of suspected retrorectal tumors begins with plain 
radiographs of the pelvis. These are typically normal and 
provide little additional information. The exceptions are 
malignant tumors that may produce bone destruction of 
the sacrum, as well as the rare benign bone-based lesions 
such as aneurismal bone cysts, giant cell tumors, and 
osteochondromas.6 Transrectal ultrasonography appears 
to have utility in establishing the diagnosis of a retrorectal 
tumor. Transrectal ultrasonography was found to have a 
sensitivity of 100% when combined with rigid proctoscopy.2,4 
Tomographic imaging, with either computed tomography or 
MRI, has become the standard for preoperative evaluation 
of retrorectal tumors. In particular, MRI with an endorectal 
coil can provide detailed images depicting the relationship 
of the tumor with sacral nerve roots, the coccyx, and the 
musculature of the pelvic floor. MRI also appears to be 
slightly more specific for establishing the histology of the 
retrorectal tumor.2
In appropriate surgical candidates, all retrorectal 
tumors should be resected, even if asymptomatic. Glasgow 
and Dietz have previously summarized the reasons for 
operative extirpation.6 For patients who are medically fit 
for an operation and in whom the lesion seems resectable, 
treatment of retrorectal lesions is almost always surgical 
resection. A suitable approach is the key to the successful 
surgical treatment of the retrorectal tumor.7 Three different 
operative approaches are commonly used in the resection of 
retrorectal tumors: abdominal, transsacral, and combined 
abdominosacral. The approach depends on the nature 
and location of the lesion. Lesions that do not extend 
below S4 (high lesions) can be resected transabdominally 
(anterior approach). Lower lesions can be resected transsacrally 
(posterior approach). If the upper extent of the lesion can 
be palpated on rectal examination, it is likely to be resectable 
transsacrally. Larger lesions or those in an intermediate 
position may require a combined abdominal and sacral   
operation.
The transsacral approach is preferred for small 
(diameter , 8 cm), benign tumors or for perineal fistu-
lae that do not extend above the level of the fourth sacral 
element.8 This approach enables good access to the caudal 
component of the tumor, as well as producing excellent 
results with minimal morbidity. As tumors are resected via 
a posterior approach the patient takes the Kraske position. 
A longitudinal or “S”-shaped incision between the coccyx and 
the posterior margin of the anus is selected, and the coccyx, 
as well as the fourth and fifth sacral vertebra, can be resected 
when necessary to achieve good exposure of the presacral 
space. In the authors’ group, 48 patients (77.4%) received a 
wholly posterior approach for low-lying tumors (ie, under the 
promontory). This supported the notion that when the superior 
border of the tumor is palpable and movable during digital 
examination, the posterior approach should be successful.2 
However, lesions above the sacral promontory or which 
are potentially malignant are amenable to the abdominal 
approach, as it provides direct visualization of the middle 
sacral artery, and the presacral veins and nerves.1
Frequently, the tumor is supplied and drained by the 
presacral vessels, which must be ligated. When large tumors 
or infected cysts involve the rectum or the presacral fascia, 
the inflammation often obscures normal planes and causes 
significant adhesion to the adjacent tissues. A combined 
abdominosacral approach is then suggested in these kinds 
of cases.9 The benefits of the combined abdominoperineal 
approach include improved visualization of structures, such 
as the ureters and the rectum itself via the anterior incision, 
as well as enhanced exposure of the nerve roots provided 
by the posterior approach. In four of the authors’ cases, the 
tumor was firstly exposed in the posterior approach, through 
which an en bloc tumor resection was difficult to perform. 
The tumor was then resected through a combined approach. 
Nevertheless, in another six cases using a direct combined 
approach, radical tumor resections were performed and 
smooth recovery was achieved. This indicates that a com-
bined abdominoperineal approach should be chosen when 
there is evidence for tumors with rectal or adjacent structure 
or organ (uterus or bladder) involvement.
The development of tumors can cause anatomical 
variations in the retrorectal space, and is always associated OncoTargets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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with an increased incidence of surgical complications 
involving the sacral plexus and sympathetic nerves, 
with an incidence reported to be 36% by Lev-Chelouche 
et al.10 Bleeding can be caused by impairment of either 
major vessels or the pre-sacral venous plexus, and is one 
of the most severe complications of presacral operations. 
Therefore, great care must be taken to avoid injury to 
the vessels. Preoperative angiography provides detailed 
information on vessel distribution and tumor blood supply, 
and is recommended for tumors of large size or malignant 
potential. In the authors’ experience, resection of presacral 
tumors should be performed under direct visualization with 
sharp dissection. Redundant blunt dissection or excessive 
suction on the sacrum should be avoided to reduce the risk 
of vessel injury. For large tumors, the sacrum and coccyx 
can be resected when necessary to achieve a good exposure 
of tumor and surrounding tissue. For cystic lesions, eliciting 
the cystic fluid helps to reduce the volume and therefore 
facilitates resection. For solid tumors, partial resection of 
the tumor within the membrane helps to differentiate tumor 
from vicinal tissues such as iliac vessel, rectum, and ureters. 
An en bloc resection is then performed. In the authors’ series, 
one case with left iliac vessels surrounded by the tumor had 
left lateral iliac artery splitting and was retrieved by vessel 
repair. Presacral venous plexus bleeding during dissection of 
presacral fascia in another two cases was stopped by Xu’s 
hemostasis procedure, which was considered most effective 
in the present authors’ experience.11
Frequently, polycystic lesions or malignant tumors in 
the retrorectal space are densely adherent to the rectum, 
which increases the incidence of rectal injury during surgi-
cal resection. Insertion of one finger into the rectal vault 
helps to differentiate the rectal muscularis and the surround-
ing fibers of the levator ani.12 Commonly, with one finger 
inserted between the tumor and rectum, an assistant could 
help to differentiate the tumor from the rectum to perform 
an en bloc excision. However, once a cystic lesion is densely 
adhered to the rectum, blunt dissection should be avoided. 
The tumor can be partially resected with its content dislodged 
and the capsule wall that neighbors the rectum preserved on 
the serous membrane of the rectum. The secretion function 
of the residual capsule wall is then destroyed with electric 
  coagulation, which minimizes the chance of rectal injury 
and pelvic cavity infection. In addition, in case of a rectal 
rupture, either rectal repair or partial rectum resection with 
anastomosis is feasible for a satisfactory preoperative bowel 
preparation. However, when the general condition of the 
patient is poor, rectal ostomy is suggested. The resection of a 
large presacral tumor is similar to the extended radical resec-
tion of a rectal carcinoma, during which inferior abdominal as 
well as pelvic nerve plexus injury is a common complication, 
resulting in post-operative urinary functional disturbance of 
7%∼70% and sexual disturbance of 25%∼100%.13 According 
to the authors’ experience, the tumor should be prosected and 
dissected along the presacral fascia and deep rectal fascia 
under direct visualization. Inferior abdominal nerves can be 
differentiated when necessary, to reduce the incidence of 
urinary or sexual function disturbance.
Benign tumors provided a better opportunity for complete 
resection than did malignant ones. In patients with tumor 
recurrence, residual cysts comprised the majority of those 
with benign lesions while local recurrence and metastasis 
was more common in those with malignancies. Commonly, 
complete resection is crucial for malignant diseases, as it 
provides the only chance for prolongation of life. Even 
partial resection provides opportunity for chemotherapy 
or radiotherapy, and therefore improves survival.10 In the 
authors’ series, three of the seven cases with tumor recurrence 
received more than three operations. Two of them were 
pathologically diagnosed multiple dermoid cysts and one was 
malignant. In the remaining four patients with malignant 
tumors, the recurrent lesions were unresectable because of 
metastasis.
Conclusion
Primary neoplasms of the retrorectal (presacral) space are 
very rare. These lesions may be congenital or acquired, benign 
or malignant. They often arise with subtle clinical symptoms, 
or they may be found incidentally during evaluation for other 
conditions. Preoperative imaging can provide useful informa-
tion for operative planning; however, it does not eliminate the 
need for surgery. Approaches for resection include posterior 
only and combined abdominoperineal, depending on the 
characteristics of the lesion. Successful treatment of these 
enigmatic lesions requires extensive knowledge of pelvic 
anatomy and expertise in pelvic surgery.
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